DK1814555T3 - S-mirtazapin til behandling af hedeture - Google Patents

S-mirtazapin til behandling af hedeture

Info

Publication number: DK1814555T3
Authority: DK; Denmark
Prior art keywords: mirtazapine; treatment; hot flushes; flushes; hot
Prior art date: 2004-11-15

Application number

DK05808013T

Other languages

English (en)

Inventor

B W M M Bernardus Peeters

Anton Egbert Peter Adang

Original Assignee

Organon Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-11-15

Filing date

2005-11-14

Publication date

2009-12-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1814555(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-11-14 Application filed by Organon Nv filed Critical Organon Nv

2009-12-07 Application granted granted Critical

2009-12-07 Publication of DK1814555T3 publication Critical patent/DK1814555T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

DK05808013T 2004-11-15 2005-11-14 S-mirtazapin til behandling af hedeture DK1814555T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP04105778		2004-11-15
PCT/EP2005/055947 WO2006051111A1 (en)	2004-11-15	2005-11-14	S-mirtazapine for the treatment of hot flush

Publications (1)

Publication Number	Publication Date
DK1814555T3 true DK1814555T3 (da)	2009-12-07

Family

ID=34929859

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05808013T DK1814555T3 (da)	2004-11-15	2005-11-14	S-mirtazapin til behandling af hedeture

Country Status (31)

Country	Link
US (4)	US20070265245A1 (da)
EP (1)	EP1814555B1 (da)
JP (1)	JP2008519810A (da)
KR (1)	KR20070085470A (da)
CN (2)	CN101056641A (da)
AR (1)	AR053780A1 (da)
AT (1)	ATE439843T1 (da)
AU (1)	AU2005303778B2 (da)
BR (1)	BRPI0517818A2 (da)
CA (1)	CA2587283C (da)
CY (1)	CY1110538T1 (da)
DE (1)	DE602005016141D1 (da)
DK (1)	DK1814555T3 (da)
ES (1)	ES2329815T3 (da)
HK (1)	HK1104235A1 (da)
HR (1)	HRP20090513T1 (da)
IL (1)	IL182767A (da)
MX (1)	MX2007005827A (da)
MY (1)	MY144089A (da)
NO (1)	NO20072285L (da)
NZ (1)	NZ554858A (da)
PE (1)	PE20061051A1 (da)
PL (1)	PL1814555T3 (da)
PT (1)	PT1814555E (da)
RS (1)	RS51138B (da)
RU (1)	RU2396957C2 (da)
SI (1)	SI1814555T1 (da)
TW (1)	TW200631584A (da)
UA (1)	UA88655C2 (da)
WO (1)	WO2006051111A1 (da)
ZA (1)	ZA200703884B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007002174A2 (en) *	2005-06-27	2007-01-04	N.V. Organon.	A method of treatment of hormone depletion induced vasomotor symptoms
US20070129611A1 (en) *	2005-12-06	2007-06-07	University Of North Texas Health Science Center At Fort Worth	System, Method and Apparatus for Assessing Menopausal or Post-Hysterectomy Symptoms
WO2007101832A1 (en) *	2006-03-06	2007-09-13	N.V. Organon	An improved method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms
MX2009005446A (es) *	2006-11-22	2009-06-02	Organon Nv	Sistema de suministro vaginal para mirtazapina.
US7645750B2 (en) *	2006-12-13	2010-01-12	Yung Shin Pharmaceutical Ind. Co., Ltd.	Method of treating symptoms of hormonal variations
JP2009018992A (ja)	2007-07-10	2009-01-29	Sumitomo Chemical Co Ltd	光学活性ミルタザピンの製造方法
US8420624B2 (en)	2007-12-04	2013-04-16	Yung Shin Pharm. Ind. Co., Ltd.	Methods for treating or preventing symptoms of hormonal variations
PT3261645T (pt)	2015-02-27	2021-06-17	Dechra Ltd	Estimulação do apetite, gestão da perda de peso, e tratamento da anorexia em cães e gatos
EP3630102B1 (en) *	2017-05-25	2024-08-14	Glytech LLC.	Formulations for treatment of post-traumatic stress disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL189199C (nl) *	1975-04-05	1993-02-01	Akzo Nv	Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4515792A (en) *	1982-09-30	1985-05-07	Ciba-Geigy Corporation	Tetracyclic heterocycles and antidepressant compositions thereof
JPH1187727A (ja) *	1997-09-12	1999-03-30	Mitsubishi Electric Corp	半導体装置
CA2326356C (en) *	1998-04-02	2008-06-03	Akzo Nobel N.V.	Oral liquid antidepressant solution

2005
- 2005-11-10 TW TW094139442A patent/TW200631584A/zh unknown
- 2005-11-14 NZ NZ554858A patent/NZ554858A/en not_active IP Right Cessation
- 2005-11-14 CN CNA200580038949XA patent/CN101056641A/zh active Pending
- 2005-11-14 ES ES05808013T patent/ES2329815T3/es active Active
- 2005-11-14 RS RSP-2009/0504A patent/RS51138B/sr unknown
- 2005-11-14 PT PT05808013T patent/PT1814555E/pt unknown
- 2005-11-14 RU RU2007122391/14A patent/RU2396957C2/ru not_active IP Right Cessation
- 2005-11-14 AU AU2005303778A patent/AU2005303778B2/en active Active
- 2005-11-14 BR BRPI0517818-5A patent/BRPI0517818A2/pt not_active IP Right Cessation
- 2005-11-14 DK DK05808013T patent/DK1814555T3/da active
- 2005-11-14 MX MX2007005827A patent/MX2007005827A/es active IP Right Grant
- 2005-11-14 US US11/667,579 patent/US20070265245A1/en not_active Abandoned
- 2005-11-14 CN CN2012102639294A patent/CN102772414A/zh active Pending
- 2005-11-14 KR KR1020077011981A patent/KR20070085470A/ko not_active Application Discontinuation
- 2005-11-14 PL PL05808013T patent/PL1814555T3/pl unknown
- 2005-11-14 UA UAA200705135A patent/UA88655C2/ru unknown
- 2005-11-14 JP JP2007540655A patent/JP2008519810A/ja active Pending
- 2005-11-14 PE PE2005001334A patent/PE20061051A1/es not_active Application Discontinuation
- 2005-11-14 EP EP05808013A patent/EP1814555B1/en active Active
- 2005-11-14 CA CA2587283A patent/CA2587283C/en not_active Expired - Fee Related
- 2005-11-14 MY MYPI20055321A patent/MY144089A/en unknown
- 2005-11-14 DE DE602005016141T patent/DE602005016141D1/de active Active
- 2005-11-14 AR ARP050104768A patent/AR053780A1/es unknown
- 2005-11-14 WO PCT/EP2005/055947 patent/WO2006051111A1/en active Application Filing
- 2005-11-14 SI SI200530802T patent/SI1814555T1/sl unknown
- 2005-11-14 AT AT05808013T patent/ATE439843T1/de active
2007
- 2007-04-23 IL IL182767A patent/IL182767A/en not_active IP Right Cessation
- 2007-04-30 NO NO20072285A patent/NO20072285L/no not_active Application Discontinuation
- 2007-05-14 ZA ZA200703884A patent/ZA200703884B/xx unknown
- 2007-11-21 HK HK07112680.3A patent/HK1104235A1/xx not_active IP Right Cessation
2009
- 2009-09-25 HR HR20090513T patent/HRP20090513T1/xx unknown
- 2009-10-12 CY CY20091101044T patent/CY1110538T1/el unknown
2010
- 2010-07-01 US US12/828,720 patent/US20100267694A1/en not_active Abandoned
2012
- 2012-08-09 US US13/570,481 patent/US20120302552A1/en not_active Abandoned
2013
- 2013-04-05 US US13/857,445 patent/US20130225559A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20070265245A1 (en)	2007-11-15
NZ554858A (en)	2009-10-30
PL1814555T3 (pl)	2010-01-29
AU2005303778B2 (en)	2011-02-17
EP1814555B1 (en)	2009-08-19
AU2005303778A1 (en)	2006-05-18
MX2007005827A (es)	2007-07-20
RU2396957C2 (ru)	2010-08-20
HK1104235A1 (en)	2008-01-11
US20120302552A1 (en)	2012-11-29
ATE439843T1 (de)	2009-09-15
UA88655C2 (ru)	2009-11-10
SI1814555T1 (sl)	2009-12-31
CA2587283A1 (en)	2006-05-18
EP1814555A1 (en)	2007-08-08
NO20072285L (no)	2007-06-13
RU2007122391A (ru)	2008-12-20
TW200631584A (en)	2006-09-16
CN102772414A (zh)	2012-11-14
US20100267694A1 (en)	2010-10-21
DE602005016141D1 (de)	2009-10-01
IL182767A (en)	2011-07-31
KR20070085470A (ko)	2007-08-27
BRPI0517818A2 (pt)	2010-03-16
CY1110538T1 (el)	2015-04-29
JP2008519810A (ja)	2008-06-12
RS51138B (sr)	2010-10-31
PT1814555E (pt)	2009-09-30
WO2006051111A1 (en)	2006-05-18
ZA200703884B (en)	2009-07-29
US20130225559A1 (en)	2013-08-29
IL182767A0 (en)	2007-09-20
MY144089A (en)	2011-08-15
AR053780A1 (es)	2007-05-23
CA2587283C (en)	2013-01-15
CN101056641A (zh)	2007-10-17
ES2329815T3 (es)	2009-12-01
HRP20090513T1 (en)	2009-10-31
PE20061051A1 (es)	2006-10-26

Publication	Publication Date	Title
DK1828164T3 (da)	2008-12-08	Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da)	2013-09-30	Fremgangsmåde til fremstilling af dihydropteridion
DK3403657T3 (da)	2022-02-28	Anvendelse af oligouronater til behandling af slimhyperviskositet
DK1893586T3 (da)	2009-01-05	Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
DK1720571T3 (da)	2012-09-03	Fremgangsmåde til behandling af hæmolytisk sygdom
DK1948176T3 (da)	2011-04-18	Diarylurinstoffer til behandling af pulmonær hypertension
DK1830843T3 (da)	2013-02-11	Indolidon-derivater til behandling eller forebyggelse af fibrotiske sygdomme
DK1874781T3 (da)	2009-11-02	Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme
DK1720866T3 (da)	2011-11-21	Fremgangsmåde
DK1877232T3 (da)	2014-08-11	Fremgangsmåde til behandling af træoverflader
DK1737461T3 (da)	2013-03-18	Carbolin-derivater til inhibering af angiogenese
DK1708992T3 (da)	2007-11-05	Sulfonamidderivater til behandling af sygdomme
DK1748077T3 (da)	2013-04-08	Fremgangsmåde til fremstilling af protein
DK3326681T3 (da)	2019-09-30	Indretning til behandling af analsphincteren
DK2117565T3 (da)	2012-11-19	Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
DK1881830T3 (da)	2009-01-26	4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater til behandling af infertilitet
EP1798476A4 (en)	2010-11-17	HEATING DEVICE
DK1630309T3 (da)	2013-08-26	Afløb
DK1801108T3 (da)	2013-02-18	Morpholinforbindelser til behandling af inflammationer.
DK1912961T3 (da)	2013-02-11	Fremgangsmåde til fremstilling af bepromolin
DK1814555T3 (da)	2009-12-07	S-mirtazapin til behandling af hedeture
DK1709082T3 (da)	2014-06-16	Sammensætning til behandling af patologi knyttet til MSRV/HERV-W
DK1831223T3 (da)	2013-06-10	Fremgangsmåde til fremstilling af L-biopterin
DK1940447T3 (da)	2014-01-20	Behandling af neurodegenrative lidelser
DK1937662T3 (da)	2009-11-30	Fremgangsmåde til fremstilling af duloxetin